News & Media

Isolation, function, and potential future uses of extracellular vesicles derived from milk – a complex and commonly overlooked biofluid.

Reflecting on the discovery, open questions and potential applications of microRNA, and microRNA derived from extracellular vesicles.

When it comes to EV storage, there are many variables to consider. Here, we share 7 factors to consider between the time of collection until samples are processed for EV isolation.

On World Cancer Day 2022, we look to progress and challenges in areas critical to the development of extracellular vesicle-based biomarkers for early cancer detection.

The Tasmanian devil species is threatened by transmissible facial tumours. Do extracellular vesicles hold the key to better conservation strategies?

Why the signal-to-noise ratio is important for EV-based diagnostics.

How tunable resistive pulse sensing (TRPS) enables precise EV measurements.

Notes from a conversation with Assistant Professor Stephanie Jung, University Hospital of Bonn (Germany), who separated Hepatitis B and antibodies from EVs to enable functional EV-virology studies.

Four reasons why storage conditions matter to the world of extracellular vesicle research.

Sharing the story of France-based researcher Dr Gwennan André-Grégoire, who is working on unravelling the EV-related pathophysiology of glioblastoma multiforme.

An optimised, clinically relevant method for proteomic analysis of plasma EVs, featuring qEV isolation, is now documented in Cell Reports Methods.

On World Hepatitis Day 2021, we explore how researchers are pursuing extracellular vesicles as a way to improve outcomes for people with hepatitis.

A summary of work by Caputo et al (2021) who conducted a side-by-side comparison of ten analytical techniques for the characterisation of nanoplastics and microplastics.

A summary of the first ISEV 2021 plenary session by Andrew Hill, La Trobe University. This presentation explored EVs and their role in neurogenerative diseases, with a particular focus on prion diseases.

A wrap-up of the second ISEV 2021 plenary talk by Chantal Boulanger, INSERM. Here, the focus was on EVs in relation to arterial contraction and myocardial infarction.

Highlights from the third ISEV 2021 plenary talk by Simon Carding, University of East Anglia, who discussed bacteria-derived EVs, their dynamics in the gut and their potential as drug delivery vehicles.

Together, the qEV Concentration Kit and qEV RNA Extraction Kit provide streamlined and standardised solutions for isolating and concentrating EVs and extracting EV-RNA for downstream analysis.

How is TRPS used to derive EV characteristics? How has a post-processing protocol created new possibilities for zeta potential analysis? Find out in this wrap-up of the ISEV2021 presentation by Dr. Priscila Dauros-Singorenko.

To help you select a suitable method for your research, we identified three key questions that get to the core of what’s important for characterising nanoparticles.

In brief: a summary of work by Vogel et al. (2021), who compared six methods for nanoparticle analysis, and assessed their capabilities using synthetic and biological nanovesicles of varying complexity.

To strengthen the analysis of nanoparticle size, concentration, and charge, Izon Science has released the Exoid – a new-generation Tunable Resistive Pulse Sensing (TRPS) technology.